Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
November 03, 2009 17:00 ET | Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Biotest Pharmaceuticals Corporation has withdrawn the claim and agreed to release the...
Nabi Biopharmaceuticals Initiates Pivotal Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
November 03, 2009 09:15 ET | Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has initiated the first of two pivotal Phase III clinical trials for NicVAX(R) (Nicotine...
DARA BioSciences, Inc. Logo
DARA BioSciences Regains NASDAQ Compliance
October 22, 2009 08:45 ET | DARA BioSciences, Inc.
RALEIGH, N.C., Oct. 22, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage biopharmaceutical company, today announced that it has received notification from The NASDAQ...
Immunomedics.png
Immunomedics to Present At 2009 UBS Global Life Sciences Conference
September 15, 2009 08:30 ET | Immunomedics, Inc.
MORRIS PLAINS, N.J., Sept. 15, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious...
Oncotelic Logo.png
OXiGENE Reports First Quarter 2009 Financial Results
May 11, 2009 16:00 ET | Mateon Therapeutics
WALTHAM, Mass., May 11, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
Nabi Biopharmaceuticals to Announce 2008 Fourth Quarter and Year-End Financial Results On March 11, 2009
March 05, 2009 09:30 ET | Nabi Biopharmaceuticals
ROCKVILLE, Md., March 5, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2008 fourth quarter and full-year financial results on Wednesday, March...
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results On November 6, 2008
October 27, 2008 15:00 ET | Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its third quarter 2008 financial results on Thursday, November 6, 2008,...
CassavaLogo2.png
Pain Therapeutics to Present At Two Upcoming Investor Conferences
June 03, 2008 09:00 ET | Cassava Sciences, Inc.
SAN MATEO, Calif., June 3, 2008 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences: *...
Icagen to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call On March 5, 2008
February 27, 2008 08:30 ET | Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2007 on Wednesday,...
Viropro Announces First Milestone Payment With Intas Biopharmaceuticals Limited
November 29, 2007 10:00 ET | Viropro, Inc.
MONTREAL, Nov. 29, 2007 (PRIME NEWSWIRE) -- Viropro Inc. (OTCBB:VPRO) is pleased to announce that its subsidiary Viropro International Inc. ("Viropro") has received payment for the first Milestone of...